Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of bone metastasis and metastasis suppressors by non-coding RNAs in breast cancer. | Biochimie | 2021 | 34019953 | PubTator, text mining | PubMed |
| Intracellular and Extracellular Roles of Granzyme K. | Front Immunol | 2021 | 34017346 | PubTator, text mining | PubMed |
| Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance. | Oncogene | 2021 | 34012098 | PubTator, text mining | PubMed |
| Proteomic Analysis on Anti-Proliferative and Apoptosis Effects of Curcumin Analog, 1,5-bis(4-Hydroxy-3-Methyoxyphenyl)-1,4-Pentadiene-3-One-Treated Human Glioblastoma and Neuroblastoma Cells. | Front Mol Biosci | 2021 | 33996900 | PubTator, text mining | PubMed |
| Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer. | Mol Ther Nucleic Acids | 2021 | 33996260 | PubTator, text mining | PubMed |
| Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer. | Onco Targets Ther | 2021 | 33986602 | PubTator, text mining | PubMed |
| Limited inhibition of multiple nodes in a driver network blocks metastasis. | Elife | 2021 | 33973518 | PubTator, text mining | PubMed |
| Control Analysis of Protein-Protein Interaction Network Reveals Potential Regulatory Targets for MYCN. | Front Oncol | 2021 | 33968733 | PubTator, text mining | PubMed |
| Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma. | Front Pharmacol | 2021 | 33967751 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid. | Cancers (Basel) | 2021 | 33946813 | PubTator, text mining | PubMed |
| 3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma. | Transl Oncol | 2021 | 33946033 | PubTator, text mining | PubMed |
| Whole-genome sequencing analysis of semi-supercentenarians. | Elife | 2021 | 33941312 | PubTator, text mining | PubMed |
| The metastasis suppressor protein NM23-H1 modulates the PI3K-AKT axis through interaction with the p110α catalytic subunit. | Oncogenesis | 2021 | 33931587 | PubTator, text mining | PubMed |
| Nanobody Conjugates for Targeted Cancer Therapy and Imaging. | Technol Cancer Res Treat | 2021 | 33929911 | PubTator, text mining | PubMed |
| Knockdown of the Ribosomal Protein eL38 in HEK293 Cells Changes the Translational Efficiency of Specific Genes. | Int J Mol Sci | 2021 | 33926116 | PubTator, text mining | PubMed |
| Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming. | Cancers (Basel) | 2021 | 33924061 | PubTator, text mining | PubMed |
| Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey. | Int J Mol Sci | 2021 | 33922356 | PubTator, text mining | PubMed |
| Phytochemicals and Bioactivities of Zingiber cassumunar Roxb. | Molecules | 2021 | 33921835 | PubTator, text mining | PubMed |
| Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells. | Int J Mol Sci | 2021 | 33918324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=31